No Data
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Could Be Less Than A Year Away From Profitability
Express News | ACADIA Pharmaceuticals Inc : BMO Initiates Coverage With Outperform Rating; Target Price $31
ACADIA Pharmaceuticals Initiated at Outperform by BMO Capital
BMO Capital Initiates Coverage On ACADIA Pharmaceuticals With Outperform Rating, Announces Price Target of $31
BMO Capital Initiates ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Announces Target Price $31
BMO Capital analyst Evan Seigerman initiates coverage on $ACADIA Pharmaceuticals(ACAD.US)$ with a buy rating, and sets the target price at $31.According to TipRanks data, the analyst has a success rat